Profile
Mark Robbins worked as Vice President-Clinical & Regulatory Affairs at DiaMedica Therapeutics, Inc. from 2013 to 2015.
He was also President at Tansna Therapeutics, Inc. and Chief Scientific Officer & EVP Legal Operations at Upsher-Smith Laboratories LLC.
Former positions of Mark Robbins
| Companies | Position | End |
|---|---|---|
Tansna Therapeutics, Inc.
 Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Tansna Therapeutics, Inc. develops and offers oral drugs to treat epilepsy. It focuses on novel therapies for the treatment of central nervous system disorders. The company was founded by Max Baker in 2010 and is headquartered in St. Louis, MO. | President | 2018-09-30 |
| DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2015-01-19 |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN. | Chief Operating Officer | 2013-01-09 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Upsher-Smith Laboratories LLC
Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN. | Health Technology |
Tansna Therapeutics, Inc.
Tansna Therapeutics, Inc. Medical DistributorsDistribution Services Tansna Therapeutics, Inc. develops and offers oral drugs to treat epilepsy. It focuses on novel therapies for the treatment of central nervous system disorders. The company was founded by Max Baker in 2010 and is headquartered in St. Louis, MO. | Distribution Services |
- Stock Market
- Insiders
- Mark Robbins
